Circulation

MARCH 19, 2025

The field of cardio-oncology has expanded over the past 2 decades to address the ever-increasing issues related to cardiovascular disease in patients with cancer and survivors.

Cancer 55

Cancer Cardio Oncology Cardiovascular Disease Pediatrics 55

Medical Xpress - Cardiology

DECEMBER 24, 2024

Cardiovascular diseases remain a global health crisis, spurring an urgent demand for innovative diagnostic tools that enable early detection and effective treatment. These cutting-edge advancements promise to enhance patient care and outcomes by providing real-time insights into heart health.

Cardiovascular Disease 87

Cardiovascular Disease Innovation Patient Care Outcomes 87

Circulation

APRIL 7, 2025

The digital determinants of health include the impact of digital technologies (eg, wearables, telemedicine) across health outcomes. Evidence of effective interventions using technology to improve cardiovascular health through positive behavior change is critical for preventing cardiovascular disease events.

Technology 74

Technology Health Disparities Cardiovascular Disease Circulation 74

Frontiers in Cardiovascular Medicine

APRIL 7, 2025

With the global impact of cardiovascular disease, there is a dire need to understand the mechanisms in the heart during injury and stress. However, epigenetic mechanisms have been shown to regulate functionality across cardiac cells and improve outcomes during stress or injury.

Cardiovascular Disease 52

Cardiovascular Disease Heart Failure Research Outcomes 52

Journal of the American Heart Association

FEBRUARY 14, 2024

One such syndrome that has been associated with poor outcomes is cognitive frailty: the simultaneous presence of cognitive impairment, without evidence of dementia, and physical frailty, which results in decreased cognitive reserve.

Cardiovascular Disease 73

Cardiovascular Disease Dementia Obesity Risk Factors 73

Medical Xpress - Cardiology

FEBRUARY 27, 2025

Hospital-based researchers from Denmark have reported a substantial increase in cardiovascular disease risk among male users of anabolic androgenic steroids (AAS). Long-term health outcomes for AAS users show extreme increases in heart-related health risks.

Cardiovascular Disease 139

Cardiovascular Disease Hospital Research Outcomes 139

Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

Despite its known correlations with risk of cardiovascular disease, awareness and testing for Lipoprotein (a) lags that of other serological markers with estimates that less than 1% of the US population have undergone screening.

Cardiovascular Disease 52

Cardiovascular Disease Biomarkers Obesity Outcomes 52

European Journal of Heart Failure

MARCH 10, 2025

Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. Abstract Aims Clonal haematopoiesis (CH) is recognized as a significant risk factor for various non-haematologic conditions, including cardiovascular diseases.

Heart Failure 40

Heart Failure Outcomes Coronary Artery Disease Risk Factors 40

DAIC

MARCH 26, 2024

milla1cf Tue, 03/26/2024 - 13:00 March 26, 2024 — Esperion announced the acceptance of three CLEAR ( C holesterol L owering via B e mpedoic acid, an A CL-Inhibiting R egimen ) Outcomes subgroup analyses as poster presentations at th e 2024 American College of Cardiology’s Annual Scientific Session ( ACC.24 24 ) in Atlanta, Georgia.

Outcomes 105

Outcomes Obesity Cardiovascular Disease Atherosclerosis 105

Medical Xpress - Cardiology

JULY 15, 2024

Dialysis patients using a more traditional home hemodialysis procedure have lower incidence of cardiovascular disease than patients using a less invasive peritoneal catheter for dialysis at home, according to a study led by a University of Cincinnati College of Medicine researcher.

Cardiovascular Disease 99

Cardiovascular Disease Outcomes Research 99

Heart BMJ

FEBRUARY 26, 2025

One in five women suffer from hypertension worldwide, and almost half of the mortality in women is caused by cardiovascular disease (CVD) (WHO). The timely launch of the Women’s Health Strategy for England in 2022 focuses attention on the changing health and needs of women across their life.

Hypertension 59

Hypertension Cardiovascular Disease Outcomes 59

Cardiometabolic Health Congress

JANUARY 16, 2025

Atherosclerosis (ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. Precision Medicine: Personalizing Prevention for Better Outcomes Precision medicine provides tools to customize prevention and treatment plans based on individual risk factors.

Atherosclerosis 59

Atherosclerosis Risk Factors Coronary Artery Disease Cardiovascular Disease 59

The New England Journal of Medicine

MARCH 28, 2025

Among participants with type 2 diabetes and cardiovascular disease, chronic kidney disease, or both, oral semaglutide (14 mg) was associated with a lower risk of cardiovascular events than placebo after 4 years of follow-up.

Diabetes 75

Diabetes Kidney Disease Cardiovascular Disease Outcomes 75

Cardiovascular Diabetology

JULY 17, 2024

The beneficial effects of fenofibrate on atherosclerotic cardiovascular disease (ASCVD) outcomes in patients with diabetes and statin treatment are unclear. We investigated the effects of fenofibrate on all-ca.

Diabetes 105

Diabetes Cardiovascular Disease Outcomes Research 105

Circulation

FEBRUARY 11, 2024

Adverse pregnancy outcomes are common among pregnant individuals and are associated with long-term risk of cardiovascular disease. Individuals with adverse pregnancy outcomes also have an increased incidence of cardiovascular disease risk factors after delivery.

Cardiovascular Disease 45

Cardiovascular Disease Outcomes Blood Pressure Risk Factors 45

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

Global progress in addressing cardiovascular diseases (CVD) has been insufficient to attain the nine WHO non-communicable disease (NCD) targets and the Sustainable Development Goal (SDG) target of reducing premature NCD mortality by one-third by 2030. This review examines the reasons for this situation to propose a way forward.

Cardiovascular Disease 59

Cardiovascular Disease Risk Factors Outcomes 59

Circulation

NOVEMBER 11, 2024

Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular risk factors in patients with hemophilia compared to the general population.

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

Frontiers in Cardiovascular Medicine

JUNE 30, 2024

Cardiovascular disease (CVD) represents the leading cause of mortality and disability all over the world. Identifying new targeted therapeutic approaches has become a priority of biomedical research to improve patient outcomes and quality of life.

Cardiovascular Disease 52

Cardiovascular Disease Quality of Life Myocardial Infarction Aneurysm 52

The New England Journal of Medicine

AUGUST 30, 2024

Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year cardiovascular disease risk among women enrolled in the Women’s Health Study.

Cholesterol 76

Cholesterol Cardiovascular Disease Outcomes 76

Frontiers in Cardiovascular Medicine

APRIL 4, 2024

On this state of the art, we summarize the available literature on the effectiveness of virtual reality on various physical and psychological outcomes in patients with atherosclerotic cardiovascular disease.

Cardiovascular Disease 49

Cardiovascular Disease Cardiac Rehabilitation Interventional Cardiology Technology 49

Cardiovascular Diabetology

JULY 15, 2024

The atherogenic index of plasma (AIP) is a critical metric for predicting cardiovascular outcomes. However, its associations with cardiovascular disease mortality (CVM) and all-cause mortality (ACM) remain unc.

Cardiovascular Disease 52

Cardiovascular Disease Outcomes Research 52

Circulation: Cardiovascular Quality & Outcomes

APRIL 3, 2025

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

Cardiovascular Disease 40

Cardiovascular Disease Outcomes Research Circulation 40

Journal of the American Heart Association

FEBRUARY 28, 2024

We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self‐reported cardiovascular outcomes (coronary heart disease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old.

Myocardial Infarction 76

Myocardial Infarction Outcomes Heart Disease Strokes 76

Frontiers in Cardiovascular Medicine

AUGUST 6, 2024

AimsHistorically, atherosclerotic cardiovascular disease (ASCVD) risk profile mitigation has had a predominant focus on low density lipoprotein cholesterol (LDL-C). On the other hand, purified eicosapentaenoic acid (EPA), but not in combination with docosahexaenoic acid (DHA), has produced favourable ASCVD outcomes.

Cardiovascular Disease 52

Cardiovascular Disease Pharmacology Cholesterol Risk Factors 52

MIBHS

JANUARY 15, 2025

Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovascular diseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries. Impaired Healing and Recovery Nicotine constricts blood vessels, reducing blood flow to surgical sites.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Blood Clot Blood Pressure Plaque 52

Medical Xpress - Cardiology

JULY 1, 2024

Implementing patient-centered palliative care therapies, including prescribing, adjusting or discontinuing medications as needed, may help control symptoms and improve quality of life for people with heart disease, according to "Palliative Pharmacotherapy for Cardiovascular Disease," a new scientific statement from the American Heart Association, published (..)

Quality of Life 45

Quality of Life Cardiovascular Disease Heart Disease Circulation 45

Medical Xpress - Cardiology

FEBRUARY 14, 2025

Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg muscles may help detect cardiovascular disease earlier than standardized tests, opening the door to earlier treatment and better outcomes.

Heart Failure 89

Heart Failure Cardiovascular Disease Research Outcomes 89

JAMA Cardiology

JANUARY 16, 2024

This prespecified analysis of the Cholesterol Lowering via Bempedoic Acid, an ATP Citrate Lyase (ACL)–Inhibiting Regimen (CLEAR) Outcomes trial investigates if bempedoic acid is associated with a reduction in the total burden of cardiovascular events in patients at high risk for cardiovascular disease.

Cholesterol 100

Cholesterol Cardiovascular Disease Outcomes 100

American College of Cardiology

MARCH 29, 2025

The goal of the phase 3b SOUL trial was to assess the cardiovascular efficacy of oral semaglutide, a GLP-1 receptor agonist, and to determine the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or both.

Kidney Disease 55

Kidney Disease Outcomes Cardiovascular Disease Diabetes 55

Circulation

FEBRUARY 28, 2024

This scientific statement outlines the current state of the art on the use of artificial intelligence algorithms and data science in the diagnosis, classification, and treatment of cardiovascular disease.

Best Practices 82

Best Practices Heart Disease Outcomes Education 82

Frontiers in Cardiovascular Medicine

JULY 14, 2024

ObjectiveThis study aimed to evaluate the integration of the Hospital-Community-Home (HCH) model with the Self-Mutual-Group (SMG) health management model for high-risk populations with cardiovascular disease in the Yuhua community of Shijiazhuang city.

Cardiovascular Disease 52

Cardiovascular Disease Quality of Life Exercise Angina 52

DAIC

FEBRUARY 3, 2025

This clearance comes in advance of disease-modifying therapies on the horizon expected to help clinicians use this biomarker to guide patients to improved cardiovascular health, saidBrad Moore, president and CEO at Roche Diagnostics North America. The development of the Tina-quant Lipoprotein (a) Gen.2 J Clin Lipidol. 2024.03.001.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

Journal of the American Heart Association

JANUARY 10, 2025

The primary outcome was risk of an ASCVD hospitalization composite outcome (myocardial infarction, coronary artery bypass graft, percutaneous coronary intervention, stroke, transient ischemic accident) after COPD hospitalization relative to before COPD hospitalization. P0.0001); for 90 days, 0.69 (95% CI, 0.640.75;P0.0001);

Coronary Artery Bypass Graft 45

Coronary Artery Bypass Graft Cardiovascular Disease Hospital Pulmonary 45

Cardiovascular Diabetology

MARCH 25, 2025

Understanding the relationship between serum ferritin levels and cardiovascular outcomes in type 2 diabetes is crucial for improving risk stratification and guiding therapeutic interventions aimed at preventin.

BMI 59

BMI Diabetes Cardiovascular Disease Outcomes 59

Journal of the American Heart Association

APRIL 10, 2025

BackgroundNarcolepsy is linked to adverse cardiovascular disease (CVD) outcomes, but few studies have examined its associations with subclinical CVD, including in children. Detection of these outcomes early in the course of narcolepsy could help reduce the burden of adverse cardiovascular events later in life.

Cardiovascular Disease 40

Cardiovascular Disease Diabetes Medicare Hypertension 40

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovascular disease within the next 30 years, according to two new science reports. and Susan F. to 61% of the U.S.

Heart Disease 105

Heart Disease Blood Pressure Cardiovascular Disease Stroke 105

Cardiovascular Diabetology

DECEMBER 5, 2023

Insulin resistance is a pivotal risk factor for cardiovascular diseases, and the triglyceride-glucose (TyG) index is a well-established surrogate of insulin resistance. This study aimed to investigate the prog.

Risk Factors 79

Risk Factors Cardiovascular Disease Outcomes Research 79